SCHEMBL26063147

SCHEMBL26063147

C=C(C)C(=O)OC(CCCCC)n1cc(-c2ccc(OC)cc2)c(=O)[nH]c1=S

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 4/20 0.36
MMP13 P45452 4/20 0.36
ADAM17 P78536 4/20 0.36
MMP1 P03956 4/20 0.36
PTPN1 P18031 1/20 0.34
ALDH1A1 P00352 4/20 0.33
PNLIP P16233 1/20 0.33
ASAH1 Q13510 1/20 0.33
CYP2C19 P33261 1/20 0.33
TYMS P04818 1/20 0.32
POLB P06746 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
MAPT P10636 1/20 0.32
GAA P10253 2/20 0.31
CYP1A1 P04798 1/20 0.31
MMP2 P08253 1/20 0.31
MMP3 P08254 1/20 0.31
KDM4E B2RXH2 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26063149 0.90 ASAH1 (0.42) PTPN1ALDH1A1ASAH1CYP2C19MEN1
SCHEMBL26063163 0.81 CYP2C19 (0.38) ALDH1A1CYP2C19MEN1KMT2AGAA
SCHEMBL26063139 0.76 ALDH1A1 (0.34) MMP9MMP1ALDH1A1CYP2C19
SCHEMBL26039859 0.76 ALDH1A1 (0.36) ALDH1A1TYMSPOLBMEN1KMT2A
SCHEMBL26063142 0.76 CYP2C19 (0.35) MMP9MMP1ALDH1A1CYP2C19MEN1
SCHEMBL26063145 0.75 MMP2 (0.34) ALDH1A1CYP2C19MMP2
SCHEMBL26034726 0.74 ALDH1A1 (0.39) ALDH1A1TYMSPOLBMEN1KMT2A
SCHEMBL26039652 0.71 TYMS (0.39) ALDH1A1TYMSMAPTGAAKDM4E
SCHEMBL26064061 0.71 GFER (0.35) ALDH1A1TYMSPOLBMEN1KMT2A
SCHEMBL26034691 0.69 TYMS (0.42) ALDH1A1TYMSPOLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230273456-A1 OPTICALLY ACTIVE DEVICES JOHNSON & JOHNSON SURGICAL VISION INC (US) 2023-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230273456-A1 OPTICALLY ACTIVE DEVICES PDE6C, PDE6D, PDE6A MMP9 1664/4885MMP13 3206/4885ADAM17 598/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.